Xidali® Tadalafil Tablets (National Medicine Approval Number: H20255227), researched and produced by Yangling Jitai Pharmaceutical Co., Ltd., is a long-acting PDE5 inhibitor prescription drug dedicated to the treatment of male erectile dysfunction (ED). With the core mission of "Scientifically improving male health and reshaping life confidence", it provides a safe, long-acting and convenient professional treatment plan for ED patients.
The main ingredient of this product is tadalafil, with a marketed specification of 20mg yellow heart-shaped film-coated tablets, adopting an on-demand administration mode. It is rapidly absorbed orally with good bioavailability, taking effect within 30 minutes to 1 hour, with a half-life of up to 17.5 hours and a drug effect lasting for 36 hours. It provides an ultra-flexible medication time window for patients, eliminating the need to deliberately plan the time between medication and sexual activity.
Its absorption and drug effect are not affected by high-fat diet, and the impact of moderate drinking is also minimal, which is more in line with daily living habits and greatly improves medication compliance and treatment experience.
In terms of pharmacological action, Xidali® Tadalafil Tablets selectively bind to the PDE5 catalytic site, competitively block its hydrolysis of cGMP, effectively increase the blood flow of the penile corpus cavernosum and enhance erectile function; at the same time, it has a low cross-inhibition rate on isozymes such as PDE6 and PDE11, greatly reducing the risk of side effects such as visual abnormalities.
Clinical studies have confirmed that the effective improvement rate of erectile function reaches 82% after 8 weeks of treatment with this product, and the improvement rate for severe ED patients also reaches 76%. It can significantly improve the sexual life satisfaction of patients and their partners, effectively alleviate patients' psychological anxiety, and enhance self-confidence and overall quality of life.
For medication, the standard recommended dose for adult males is 20mg per time, and the dose can be adjusted according to individual efficacy, tolerance and liver and kidney function. Elderly patients over 65 years old do not need dose adjustment due to age, and its use is not recommended for people under 18 years old.
This product has a clear metabolic pathway, mainly metabolized by CYP3A4 enzyme, with inactive metabolites, little impact on liver and kidney function and good safety.
However, it should be noted that this product is strictly prohibited to be used in combination with nitrates, and the dose must be adjusted according to the doctor's advice when used in combination with alpha-blockers, strong CYP3A4 inhibitors and other drugs.
As an excellent choice for ED treatment, Xidali® Tadalafil Tablets, relying on the differentiated advantages of long-acting, convenience and safety, breaks the time limit of traditional drugs, makes intimate behavior more natural and calm, and helps ED patients return to a high-quality life and reshape intimate relationships.
Warm Reminder: This product is a prescription drug and must be used under the guidance of a doctor. It is forbidden for those who are allergic to tadalafil or the excipients of this product. Special populations such as patients with cardiovascular diseases and severe liver and kidney insufficiency must strictly follow the doctor's advice for medication evaluation.
邮箱
Email*
*